This is a Sponsored Post written by me on behalf of CryoCell International. All opinions are 100% mine.
Can a stem cell research company be as committed to protecting the rights of unborn babies as you are? Believe it or not, the answer is yes.
Rather than focusing on fetal stem cells, Cryo-Cell International, committed to protecting and preserving life, collects adult stem cells to further their research. Since 1992, Cryo-Cell has helped almost 200,000 families worldwide preserve the umbilical cord blood from their new born babies. These stem cells can be used to combat many diseases. Along with cord blood banking, Cryo-Cell is pioneering other noncontroversial solutions to collecting and preserving stem cells.
Cryo-Cell made the breakthrough discovery that menstrual blood is a viable, renewable, prolific source of stem cells. From that they launched C’elle SM, their revolutionary menstrual stem cell service which has made astounding research advancements in just a few years.
From the C’elle Blog :
Since the launch of Célle in 2007, Cryo-Cell has announced eight research and development collaborations that may possibly lead to the treatment or cure of conditions such as stroke, diabetes, heart disease, breast cancer, wound-healing, vascular regeneration, endometriosis and urinary incontinence. Cryo-Cell is extraordinarily fortunate to partner with some of the world’s most distinguished stem cell researchers who are exploring therapeutic developments that utilize our menstrual stem cell technology and who are as excited about the potential of Célle technology as we are.
Stem cells from umbilical cord blood has been utilized to treat or cure more than 75 diseases, and used in over 12,000 transplants worldwide. During the last three years at Cryo-Cell their cord blood stem cell transplants have increased by 135%. That is absolutely awesome news.